Stocks and Investing Stocks and Investing
Thu, March 1, 2012

VERENIUM CORP (NASDAQ:VRNM), Up By 6.61% ($0.18) After BUYINS.NET SqueezeTrigger Report Released on Monday, February 27th 2012


Published on 2012-03-01 07:42:00 - WOPRAI
  Print publication without navigation


March 1, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, released a report on Monday, February 27th 2012 at 09:16:00 PST stating that VERENIUM CORP (NASDAQ:VRNM) was expected to be Up After it crossed above its SqueezeTrigger Price of 2.77 on Monday, February 27th 2012. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=vrnm&id=247614

From August 2009 to January 2012, an aggregate amount of 31664789 shares of VRNM have been shorted for a total dollar value of $63329578. The VRNM SqueezeTrigger price of $2.77 is the volume weighted average price that all shorts are short in shares of VRNM. There is still approximately $759,144 of potential short covering in shares of VRNM.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger Price for each stock that has been shorted. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of short squeeze events. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com .

VERENIUM CORP (NASDAQ:VRNM) - Verenium Corporation engages in the development and production of specialty enzyme products, and production and commercialization of biofuels. It operates in two segments, Biofuels and Specialty Enzymes. The Biofuels segment focuses on the production and commercialization of biofuels, primarily ethanol from cellulosic biomass. The Specialty Enzymes segment develops enzymes for use in alternative fuels, specialty industrial processes, and animal nutrition and health markets. Its products include FuelzymeLF, an alpha amylase enzyme, which is designed to improve the efficiency and economics of ethanol production from corn and other grain or starch sources; Purifine enzyme for biodiesel applications; and Veretase enzyme that could be used in food applications in the production of potable alcohol, such as vodka or gin, and sugars for sweeteners, such as glucose or high fructose corn syrup. This segments products also comprise Deltazym enzyme, a glucoamylase used in grain ethanol processing; Xylathin enzyme that is designed to improve the economics of fuel ethanol production from cereal grains; Purifine for enhanced processing of edible nutritional oil; Luminase for pulp and paper processing; and Phyzyme XP animal feed enzyme. The company has operations in North America, South America, Europe, Asia, and the Middle East. It has strategic collaborations with Syngenta AG; Bunge Oils, Inc.; Cargill Health and Food Technologies; BASF AG; BP; and United States Department of Energy. The company was formerly known as Diversa Corporation and changed its name to Verenium Corporation in June 2007 as a result of the merger with Celunol Corp. Verenium Corporation was founded in 1992 and is based in Cambridge, Massachusetts.

The SqueezeTrigger database of approximately 1 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources